Format

Send to

Choose Destination
J Thorac Dis. 2012 Apr 1;4(2):219-20. doi: 10.3978/j.issn.2072-1439.2012.03.03.

EURTAC first-line phase III randomized study in advanced non-small cell lung cancer: Erlotinib works also in European population.

Author information

1
Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy.

Supplemental Content

Full text links

Icon for AME Publishing Company Icon for PubMed Central
Loading ...
Support Center